{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:35:46Z","timestamp":1794353746141,"version":"4.9.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T00:00:00Z","timestamp":1765584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The role of RNA N\n                    <jats:sup>6<\/jats:sup>\n                    -methyladenoine (m\n                    <jats:sup>6<\/jats:sup>\n                    A) eraser AlkB homologue 5 (ALKBH5) in colorectal cancer (CRC) stem cells (CSCs) is unclear. Here, we find that ALKBH5 expression positively correlates with CSC markers in CRC patients. ALKBH5 induces self-renewal and stemness markers in colorectal CSCs and patient-derived organoids (PDOs). Colon-stem cell specific\n                    <jats:italic>Alkbh5<\/jats:italic>\n                    knockin accelerates carcinogen-induced CRC, while tumorigenesis is attenuated in colon-stem cell specific\n                    <jats:italic>Alkbh5<\/jats:italic>\n                    knockout mice. Integrated RNA-seq, MeRIP-seq and Ribo-seq reveal FAM84A as an ALKBH5 target. ALKBH5 demethylates m\n                    <jats:sup>6<\/jats:sup>\n                    A-modified FAM84A mRNA, causing mRNA decay and reduced expression. Mechanistically, we show that FAM84A represses CSCs by interacting with \u03b2-catenin and promoting \u03b2-catenin ubiquitination and degradation. By boosting CSCs, ALKBH5 overexpression elicit chemoresistance in CSCs, PDOs and transgenic mice. Targeting of ALKBH5 by knockout or VNPs-siALKBH5 synergizes with chemotherapy to trigger tumor regression in CSCs-\/PDOs-derived xenografts and ALKBH5 knockout mice. Together, we reveal that ALKBH5 is essential for colorectal CSCs and is a therapeutic target for overcoming CRC chemoresistance.\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-67502-0","type":"journal-article","created":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:07:05Z","timestamp":1765613225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Targeting of the m6A eraser ALKBH5 suppresses stemness and chemoresistance of colorectal cancer"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5460-3438","authenticated-orcid":false,"given":"Heming","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2192-1864","authenticated-orcid":false,"given":"Huarong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1650-0371","authenticated-orcid":false,"given":"Weixin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin Ho Kwan","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuet","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4651-677X","authenticated-orcid":false,"given":"Wei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4607-4999","authenticated-orcid":false,"given":"Henley","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7740-6696","authenticated-orcid":false,"given":"Yanqiang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinyao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1941-3951","authenticated-orcid":false,"given":"Sujun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1362-3541","authenticated-orcid":false,"given":"Chi Chun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3435-6550","authenticated-orcid":false,"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,13]]},"reference":[{"key":"67502_CR1","first-page":"233","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA Cancer J. Clin. 73, 233\u2013254 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"67502_CR2","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse, R. & Clevers, H. Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities. Cell 169, 985\u2013999 (2017).","journal-title":"Cell"},{"key":"67502_CR3","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nature06196","volume":"449","author":"N Barker","year":"2007","unstructured":"Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003\u20131007 (2007).","journal-title":"Nature"},{"key":"67502_CR4","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1126\/science.1224676","volume":"337","author":"AG Schepers","year":"2012","unstructured":"Schepers, A. G. et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 337, 730\u2013735 (2012).","journal-title":"Science"},{"key":"67502_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature14415","volume":"521","author":"J Drost","year":"2015","unstructured":"Drost, J. et al. Sequential cancer mutations in cultured human intestinal stem cells. Nature 521, 43\u201347 (2015).","journal-title":"Nature"},{"key":"67502_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.stem.2007.08.001","volume":"1","author":"M Todaro","year":"2007","unstructured":"Todaro, M. et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 1, 389\u2013402 (2007).","journal-title":"Cell Stem Cell"},{"key":"67502_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abl5723","volume":"8","author":"T Zhang","year":"2022","unstructured":"Zhang, T. et al. m6A mRNA modification maintains colonic epithelial cell homeostasis via NF-\u03baB-mediated antiapoptotic pathway. Sci. Adv. 8, eabl5723 (2022).","journal-title":"Sci. Adv."},{"key":"67502_CR8","doi-asserted-by":"crossref","unstructured":"Danan, C. H. et al. Intestinal transit-amplifying cells require METTL3 for growth factor signaling and cell survival. JCI Insight 8, e171657 (2023).","DOI":"10.1172\/jci.insight.171657"},{"key":"67502_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103647","volume":"83","author":"C Xu","year":"2025","unstructured":"Xu, C. et al. FTO facilitates colorectal cancer chemoresistance via regulation of NUPR1-dependent iron homeostasis. Redox Biol. 83, 103647 (2025).","journal-title":"Redox Biol."},{"key":"67502_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.217254","volume":"604","author":"Y-T Tan","year":"2024","unstructured":"Tan, Y.-T. et al. WTAP weakens oxaliplatin chemosensitivity of colorectal cancer by preventing PANoptosis. Cancer Lett. 604, 217254 (2024).","journal-title":"Cancer Lett."},{"key":"67502_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155906","volume":"133","author":"X Lin","year":"2024","unstructured":"Lin, X. et al. Gegen Qinlian Decoction reverses oxaliplatin resistance in colorectal cancer by inhibiting YTHDF1-regulated m6A modification of GLS1. Phytomedicine 133, 155906 (2024).","journal-title":"Phytomedicine"},{"key":"67502_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216420","volume":"576","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. LIMK1 m6A-RNA methylation recognized by YTHDC2 induces 5-FU chemoresistance in colorectal cancer via endoplasmic reticulum stress and stress granule formation. Cancer Lett. 576, 216420 (2023).","journal-title":"Cancer Lett."},{"key":"67502_CR13","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41419-023-06099-y","volume":"14","author":"L-J Chen","year":"2023","unstructured":"Chen, L.-J. et al. IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner. Cell Death Dis. 14, 581 (2023).","journal-title":"Cell Death Dis."},{"key":"67502_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.ymthe.2022.10.012","volume":"31","author":"Z Lin","year":"2023","unstructured":"Lin, Z. et al. N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis. Mol. Ther. 31, 517\u2013534 (2023).","journal-title":"Mol. Ther."},{"key":"67502_CR15","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.7150\/ijbs.95375","volume":"20","author":"J Wu","year":"2024","unstructured":"Wu, J. et al. METTL16 Promotes Stability of SYNPO2L mRNA and leading to Cancer Cell Lung Metastasis by Secretion of COL10A1 and attract the Cancer-Associated Fibroblasts. Int. J. Biol. Sci. 20, 4128\u20134145 (2024).","journal-title":"Int. J. Biol. Sci."},{"key":"67502_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13046-024-03035-6","volume":"43","author":"P Ouyang","year":"2024","unstructured":"Ouyang, P. et al. METTL3 recruiting M2-type immunosuppressed macrophages by targeting m6A-SNAIL-CXCL2 axis to promote colorectal cancer pulmonary metastasis. J. Exp. Clin. Cancer Res. 43, 111 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"67502_CR17","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13046-023-02881-0","volume":"42","author":"X Wang","year":"2023","unstructured":"Wang, X., Liu, Y., Zhou, M., Yu, L. & Si, Z. m6A modified BACE1-AS contributes to liver metastasis and stemness-like properties in colorectal cancer through TUFT1 dependent activation of Wnt signaling. J. Exp. Clin. Cancer Res. 42, 306 (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"67502_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13062-024-00551-5","volume":"19","author":"J Yu","year":"2024","unstructured":"Yu, J. et al. ALKBH5 activates CEP55 transcription through m6A demethylation in FOXP2 mRNA and expedites cell cycle entry and EMT in ovarian cancer. Biol. Direct 19, 105 (2024).","journal-title":"Biol. Direct"},{"key":"67502_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13046-024-03073-0","volume":"43","author":"X Hua","year":"2024","unstructured":"Hua, X. et al. ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages. J. Exp. Clin. Cancer Res. 43, 164 (2024).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"67502_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2024.134690","volume":"473","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. The demethylase ALKBH5 mediates ZKSCAN3 expression through the m6A modification to activate VEGFA transcription and thus participates in MNNG-induced gastric cancer progression. J. Hazard. Mater. 473, 134690 (2024).","journal-title":"J. Hazard. Mater."},{"key":"67502_CR21","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.7150\/thno.94161","volume":"14","author":"X Xu","year":"2024","unstructured":"Xu, X. et al. FSH induces EMT in ovarian cancer via ALKBH5-regulated Snail m6A demethylation. Theranostics 14, 2151\u20132166 (2024).","journal-title":"Theranostics"},{"key":"67502_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02223-4","volume":"24","author":"Z Zheng","year":"2025","unstructured":"Zheng, Z. et al. ALKBH5 suppresses gastric cancer tumorigenesis and metastasis by inhibiting the translation of uncapped WRAP53 RNA isoforms in an m6A-dependent manner. Mol. Cancer 24, 19 (2025).","journal-title":"Mol. Cancer"},{"key":"67502_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2023.101683","volume":"34","author":"J Ge","year":"2023","unstructured":"Ge, J. et al. RNA demethylase ALKBH5 suppresses tumorigenesis via inhibiting proliferation and invasion and promoting CD8+ T cell infiltration in colorectal cancer. Transl. Oncol. 34, 101683 (2023).","journal-title":"Transl. Oncol."},{"key":"67502_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01522-y","volume":"21","author":"Y Hu","year":"2022","unstructured":"Hu, Y. et al. Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification. Mol. Cancer 21, 34 (2022).","journal-title":"Mol. Cancer"},{"key":"67502_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s11010-022-04541-x","volume":"478","author":"W Li","year":"2023","unstructured":"Li, W., Huang, G., Wei, J., Cao, H. & Jiang, G. ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2\/HO-1 axis. Mol. Cell. Biochem. 478, 729\u2013741 (2023).","journal-title":"Mol. Cell. Biochem."},{"key":"67502_CR26","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/s41419-021-04401-4","volume":"12","author":"Y He","year":"2021","unstructured":"He, Y. et al. ALKBH5-mediated m6A demethylation of KCNK15-AS1 inhibits pancreatic cancer progression via regulating KCNK15 and PTEN\/AKT signaling. Cell Death Dis. 12, 1121 (2021).","journal-title":"Cell Death Dis."},{"key":"67502_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114032","volume":"43","author":"L Cao","year":"2024","unstructured":"Cao, L. et al. A LATS2 and ALKBH5 positive feedback loop supports their oncogenic roles. Cell Rep. 43, 114032 (2024).","journal-title":"Cell Rep."},{"key":"67502_CR28","doi-asserted-by":"crossref","unstructured":"Zhang, S. et al. m6A demethylase ALKBH5 maintains tumorigenicity of glioblastoma stem-like cells by sustaining FOXM1 expression and cell proliferation program. Cancer Cell 31, 591\u2013606 (2017).","DOI":"10.1016\/j.ccell.2017.02.013"},{"key":"67502_CR29","doi-asserted-by":"crossref","first-page":"E2047","DOI":"10.1073\/pnas.1521518113","volume":"113","author":"C Zhang","year":"2016","unstructured":"Zhang, C. et al. Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m\u2076A-demethylation of NANOG mRNA. Proc. Natl. Acad. Sci. USA 113, E2047\u2013E2056 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"67502_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.113163","volume":"42","author":"Y Gao","year":"2023","unstructured":"Gao, Y. et al. ALKBH5 modulates hematopoietic stem and progenitor cell energy metabolism through m6A modification-mediated RNA stability control. Cell Rep. 42, 113163 (2023).","journal-title":"Cell Rep."},{"key":"67502_CR31","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1158\/1541-7786.MCR-23-0720","volume":"22","author":"Y Meng","year":"2024","unstructured":"Meng, Y. et al. Hepatitis B virus-mediated m6A demethylation increases hepatocellular carcinoma stemness and immune escape. Mol. Cancer Res. 22, 642\u2013655 (2024).","journal-title":"Mol. Cancer Res."},{"key":"67502_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-020-00265-z","volume":"9","author":"G Chen","year":"2020","unstructured":"Chen, G. et al. Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA. Oncogenesis 9, 81 (2020).","journal-title":"Oncogenesis"},{"key":"67502_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102993","volume":"69","author":"X Liu","year":"2024","unstructured":"Liu, X. et al. M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer. Redox Biol. 69, 102993 (2024).","journal-title":"Redox Biol."},{"key":"67502_CR34","doi-asserted-by":"crossref","unstructured":"Shen, C. et al. RNA demethylase ALKBH5 selectively promotes tumorigenesis and cancer stem cell self-renewal in acute myeloid leukemia. Cell Stem Cell 27, 64\u201380 (2020).","DOI":"10.1016\/j.stem.2020.04.009"},{"key":"67502_CR35","doi-asserted-by":"crossref","unstructured":"Vasaikar, S. et al. Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities. Cell 177, 1035\u20131049 (2019).","DOI":"10.1016\/j.cell.2019.03.030"},{"key":"67502_CR36","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1038\/emboj.2012.166","volume":"31","author":"J Mu\u00f1oz","year":"2012","unstructured":"Mu\u00f1oz, J. et al. The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent \u2018+4\u2019 cell markers. EMBO J. 31, 3079\u20133091 (2012).","journal-title":"EMBO J."},{"key":"67502_CR37","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","volume":"52","author":"H-O Lee","year":"2020","unstructured":"Lee, H.-O. et al. Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer. Nat. Genet. 52, 594\u2013603 (2020).","journal-title":"Nat. Genet."},{"key":"67502_CR38","first-page":"641","volume":"53","author":"SB Ho","year":"1993","unstructured":"Ho, S. B. et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res. 53, 641\u2013651 (1993).","journal-title":"Cancer Res."},{"key":"67502_CR39","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1038\/s41388-021-01882-7","volume":"40","author":"S Gao","year":"2021","unstructured":"Gao, S. et al. CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancer. Oncogene 40, 6601\u20136613 (2021).","journal-title":"Oncogene"},{"key":"67502_CR40","doi-asserted-by":"publisher","first-page":"5684","DOI":"10.1093\/nar\/gkaa269","volume":"48","author":"J Li","year":"2020","unstructured":"Li, J. et al. Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein. Nucleic Acids Res. 48, 5684\u20135694 (2020).","journal-title":"Nucleic Acids Res."},{"key":"67502_CR41","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3389\/fphar.2018.01260","volume":"9","author":"S Rezvantalab","year":"2018","unstructured":"Rezvantalab, S. et al. PLGA-based nanoparticles in cancer treatment. Front. Pharm. 9, 1260 (2018).","journal-title":"Front. Pharm."},{"key":"67502_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31663-z","volume":"13","author":"CC Wong","year":"2022","unstructured":"Wong, C. C. et al. The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC\/KRAS-mutant colorectal cancer. Nat. Commun. 13, 3971 (2022).","journal-title":"Nat. Commun."},{"key":"67502_CR43","doi-asserted-by":"crossref","unstructured":"Yin, R. et al. Differential m6A RNA landscapes across hematopoiesis reveal a role for IGF2BP2 in preserving hematopoietic stem cell function. Cell Stem Cell 29, 149\u2013159 (2022).","DOI":"10.1016\/j.stem.2021.09.014"},{"key":"67502_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1279","volume":"13","author":"D Shen","year":"2023","unstructured":"Shen, D. et al. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner. Clin. Transl. Med. 13, e1279 (2023).","journal-title":"Clin. Transl. Med."},{"key":"67502_CR45","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1053\/j.gastro.2023.04.032","volume":"165","author":"J Zhai","year":"2023","unstructured":"Zhai, J. et al. ALKBH5 drives immune suppression via targeting AXIN2 to promote colorectal cancer and is a target for boosting immunotherapy. Gastroenterology 165, 445\u2013462 (2023).","journal-title":"Gastroenterology"},{"key":"67502_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.940","volume":"12","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z. et al. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation. Clin. Transl. Med. 12, e940 (2022).","journal-title":"Clin. Transl. Med."},{"key":"67502_CR47","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.7150\/thno.49345","volume":"11","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. IGF2BP1 overexpression stabilizes PEG10 mRNA in an m6A-dependent manner and promotes endometrial cancer progression. Theranostics 11, 1100\u20131114 (2021).","journal-title":"Theranostics"},{"key":"67502_CR48","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/nar\/gky1012","volume":"47","author":"S Muller","year":"2019","unstructured":"Muller, S. et al. IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner. Nucleic Acids Res. 47, 375\u2013390 (2019).","journal-title":"Nucleic Acids Res."},{"key":"67502_CR49","first-page":"341","volume":"29","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi, T. et al. A gene encoding a family with sequence similarity 84, member A (FAM84A) enhanced migration of human colon cancer cells. Int. J. Oncol. 29, 341\u2013347 (2006).","journal-title":"Int. J. Oncol."},{"key":"67502_CR50","first-page":"1511","volume":"38","author":"H Kamino","year":"2011","unstructured":"Kamino, H. et al. Nuclear receptor CAR-regulated expression of the FAM84A gene during the development of mouse liver tumors. Int. J. Oncol. 38, 1511\u20131520 (2011).","journal-title":"Int. J. Oncol."},{"key":"67502_CR51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0092-8674(02)01014-0","volume":"111","author":"M van de Wetering","year":"2002","unstructured":"van de Wetering, M. et al. The beta-catenin\/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241\u2013250 (2002).","journal-title":"Cell"},{"key":"67502_CR52","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0092-8674(02)01015-2","volume":"111","author":"E Batlle","year":"2002","unstructured":"Batlle, E. et al. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB\/ephrinB. Cell 111, 251\u2013263 (2002).","journal-title":"Cell"},{"key":"67502_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217439","volume":"612","author":"C Wang","year":"2025","unstructured":"Wang, C. et al. ALKBH5 facilitates tumor progression via an m6A-YTHDC1-dependent mechanism in glioma. Cancer Lett. 612, 217439 (2025).","journal-title":"Cancer Lett."},{"key":"67502_CR54","doi-asserted-by":"publisher","first-page":"10879","DOI":"10.1093\/nar\/gkae707","volume":"52","author":"Z Liang","year":"2024","unstructured":"Liang, Z. et al. ALKBH5 governs human endoderm fate by regulating the DKK1\/4-mediated Wnt\/\u03b2-catenin activation. Nucleic Acids Res. 52, 10879\u201310896 (2024).","journal-title":"Nucleic Acids Res."},{"key":"67502_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1128-6","volume":"19","author":"B Tang","year":"2020","unstructured":"Tang, B. et al. m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling. Mol. Cancer 19, 3 (2020).","journal-title":"Mol. Cancer"},{"key":"67502_CR56","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10495-020-01591-8","volume":"25","author":"O Shriwas","year":"2020","unstructured":"Shriwas, O. et al. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m(6)A-demethylation of FOXM1 and NANOG. Apoptosis 25, 233\u2013246 (2020).","journal-title":"Apoptosis"},{"key":"67502_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semcancer.2022.12.004","volume":"88","author":"GP Nagaraju","year":"2023","unstructured":"Nagaraju, G. P., Farran, B., Luong, T. & El-Rayes, B. F. Understanding the molecular mechanisms that regulate pancreatic cancer stem cell formation, stemness and chemoresistance: A brief overview. Semin. Cancer Biol. 88, 67\u201380 (2023).","journal-title":"Semin. Cancer Biol."},{"key":"67502_CR58","first-page":"2","volume":"21","author":"EO Field","year":"1961","unstructured":"Field, E. O., Kriss, J. P. & Tung, L. A. Turnover of thymidine in the DNA of marrow and intestinal mucosa in mice, and its response to administration of 5-fluorouracil. Cancer Res. 21, 2\u20138 (1961).","journal-title":"Cancer Res."},{"key":"67502_CR59","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrc2167","volume":"7","author":"L Kelland","year":"2007","unstructured":"Kelland, L. The resurgence of platinum-based cancer chemotherapy. Nat. Rev. Cancer 7, 573\u2013584 (2007).","journal-title":"Nat. Rev. Cancer"},{"key":"67502_CR60","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nature11252","volume":"487","author":"Cancer Genome Atlas, N","year":"2012","unstructured":"Cancer Genome Atlas, N Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330\u2013337 (2012).","journal-title":"Nature"},{"key":"67502_CR61","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41588-022-01088-x","volume":"54","author":"WR Becker","year":"2022","unstructured":"Becker, W. R. et al. Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer. Nat. Genet. 54, 985\u2013995 (2022).","journal-title":"Nat. Genet."},{"key":"67502_CR62","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1016\/j.cell.2023.11.004","volume":"186","author":"X Qin","year":"2023","unstructured":"Qin, X. et al. An oncogenic phenoscape of colonic stem cell polarization. Cell 186, 5554\u20135568 e5518 (2023).","journal-title":"Cell"},{"key":"67502_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2012.28","volume":"1","author":"NM Belliveau","year":"2012","unstructured":"Belliveau, N. M. et al. Microfluidic synthesis of highly potent limit-size lipid nanoparticles for in vivo delivery of siRNA. Mol. Ther. Nucleic Acids 1, e37 (2012).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"67502_CR64","doi-asserted-by":"publisher","first-page":"7930","DOI":"10.1021\/acs.analchem.5b04853","volume":"88","author":"C Arlt","year":"2016","unstructured":"Arlt, C. et al. Integrated workflow for structural proteomics studies based on cross-linking\/mass spectrometry with an MS\/MS cleavable cross-linker. Anal. Chem. 88, 7930\u20137937 (2016).","journal-title":"Anal. Chem."},{"key":"67502_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v028.i05","volume":"28","author":"M Kuhn","year":"2008","unstructured":"Kuhn, M. Building predictive models in R using the caret package. J. Stat. Softw. 28, 1\u201326 (2008).","journal-title":"J. Stat. Softw."},{"key":"67502_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 12, 77 (2011).","journal-title":"BMC Bioinform."},{"key":"67502_CR67","doi-asserted-by":"publisher","first-page":"D1211","DOI":"10.1093\/nar\/gky869","volume":"47","author":"J Ma","year":"2019","unstructured":"Ma, J. et al. iProX: an integrated proteome resource. Nucleic Acids Res. 47, D1211\u2013d1217 (2019).","journal-title":"Nucleic Acids Res."},{"key":"67502_CR68","doi-asserted-by":"publisher","first-page":"D1522","DOI":"10.1093\/nar\/gkab1081","volume":"50","author":"T Chen","year":"2022","unstructured":"Chen, T. et al. iProX in 2021: connecting proteomics data sharing with big data. Nucleic Acids Res. 50, D1522\u2013d1527 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67502-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67502-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67502-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T00:10:44Z","timestamp":1769213444000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-67502-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,13]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67502"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-67502-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,13]]},"assertion":[{"value":"21 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"803"}}